The report “Cardiac Marker Testing Market is on a robust growth trajectory, with a projected valuation of USD 7.7 billion by 2027, up from USD 5.0 billion in 2022, reflecting a notable Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period. One of the driving …
The report “Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) – Global Forecast to 2027″, projected to reach USD 7.7 billion by 2027 from USD 5.0 billion …
Cardiac Marker Testing Market is projected to reach USD 7.7 billion by 2027 from USD 5.0 billion in 2022, at a CAGR of 8.7% during the forecast period. The major factors such as rising geriatric population globally and the subsequent increase in chronic heart conditions; the …
This report aims to provide detailed insights into the global Cardiac Marker Testing Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market …
The growing incidence of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public and private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers. However, factors such as technical problems related to sample collection and storage …
A number of factors such as growing incidences of cardiovascular diseases, the rapidly increasing geriatric population, growing funding from public–private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are fueling the growth of the cardiac marker …